Is Lilly Stock A Sell After Its Disastrous Third-Quarter Report?
Eli Lilly (LLY) stock took a beating in late October after the drugmaker reported a rare sales miss for its diabetes and weight-loss drugs, Mounjaro and Zepbound. ↑ X NOW…
Microsoft Whacked On Earnings; Is It A Buy Or Sell?
Enterprise software juggernaut Microsoft (MSFT), like most tech stocks, had started September on the wrong foot. But Microsoft stock reversed bullishly, gaining more than 3% for the month. And in…